Nationality
Canada, US
Year of Birth
1958
1983
Queen’s University, Kingston, Canada, M.D
1989
California Institute of Technology, Pasadena, Biology, M.Sc.
1994
University of California, San Francisco, Neuroscience, Ph.D.
1994–1998
Stanford University, Biochemistry, Postdoctoral fellow
1984-1987
Harvard Medical School, Resident in Neurology
1987
Harvard Medical School, Chief Resident in Neurology
1989–1998
University of California, San Francisco, Adjunct Clinical Appointment in the Department of Neurology
1997–2006
Cytokinetics, Co-founder, President and CEO
2008–2010
Arete Therapeutics, President and CEO
2010–2013
Genentech Partnering, Global Head and Vice President
2013–2018
Genentech Partnering, Global Head and Senior Vice President
Since 2018
Roche Basel, Global Head of Pharma Partnering
–
–
Since 1998
Member of Scientific Advisory Board at Cytokinetics
2005–2016
Member of the Board of Directors of HopeLab
2007–2008
Executive Chairman of the Board of Directors of Cytokinetics
2008–2010
Chairman of the Board of Directors of Cytokinetics
2015–2016
Member of the Board of Directors of California Life Sciences Association
2016–2020
Member of the Board of Directors of Coalition for the Life Sciences
Since 2019
Member of the Board of Directors, Chugai Pharmaceutical Co., Ltd
–
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.